Literature DB >> 17050932

Cerebrotendinous xanthomatosis: need for early diagnosis.

K Muhammed1, G Nandakumar, S Saritha.   

Abstract

Cerebrotendinous xanthomatosis is a rare autosomal recessive lipid storage disease characterized by widespread tissue deposition of two neutral sterols, cholestanol and cholesterol, resulting in tendinous xanthomas, juvenile cataracts, progressive neurological defects and premature death from arteriosclerosis. The primary biochemical defect is deficiency of hepatic mitochondrial enzyme sterol-27-hydroxylase which catalyses the hydroxylation of cholestanol (5-alpha dehydro derivative of cholesterol) and this deficiency decreases bile acid synthesis. Substantial elevation of serum cholestanol and urinary bile alcohols with low to normal plasma cholesterol concentration establishes the diagnosis. Cerebrotendinous xanthomatosis is exceptionally rare in the Indian population. We are reporting a woman with this rare disorder, who was on antiepileptic and antipsychotic drugs for a prolonged period and whose original condition went undiagnosed. She presented with xanthomas on the Achilles tendons and the upper end of tibia. She was mentally subnormal and her serum cholestanol level was raised. Her younger sister too was severely affected by this disorder. Early treatment with chenodeoxycholic acid is known to prevent disease progression.

Entities:  

Mesh:

Year:  2006        PMID: 17050932     DOI: 10.4103/0378-6323.27754

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  6 in total

1.  Cerebrotendinous xanthomatosis.

Authors:  Mahesh Kamate; Vivek Chetal; Virupaxi Hattiholi
Journal:  Indian J Pediatr       Date:  2010-05-07       Impact factor: 1.967

2.  Cerebrotendinous xanthomatosis; a genetic condition: Clinical profile of three patients from a rural Indian family and review of literature.

Authors:  Vikas Saxena; Pavan Pradhan
Journal:  J Clin Orthop Trauma       Date:  2016-03-04

3.  Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy.

Authors:  Germaine Pierre; Kenneth Setchell; Jacqueline Blyth; Mary Anne Preece; Anupam Chakrapani; Patrick McKiernan
Journal:  J Inherit Metab Dis       Date:  2008-12-27       Impact factor: 4.982

4.  Cerebrotendinous xanthomatosis associated with immune thrombocytopenia.

Authors:  Noha M El Husseiny
Journal:  BMJ Case Rep       Date:  2010-11-05

5.  Cerebrotendinous Xanthomatosis: Report of two cases and a novel genetic mutation in an Indian patient.

Authors:  Bhupender K Bajaj; Anand Singh; Kuljeet S Anand; Jyoti Garg
Journal:  J Neurosci Rural Pract       Date:  2013-08

6.  Role of Cytology in Early Diagnosis of Cerebrotendinous Xanthomas.

Authors:  Shreosee Roy; Arghya Bandyopadhyay; Kaushik Bose; Soumi Bhattacharyya
Journal:  J Cytol       Date:  2017 Oct-Dec       Impact factor: 1.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.